Polymorphisms in genes hydroxysteroid-dehydrogenase-17b type 2 and type 4 and endometrial cancer risk

Gynecologic Oncology

Volumn 121, Issue 1, 2011, Pages 54-58

  Karageorgi, Stalo ^a   McGrath, Monica ^a,b   Lee, I Min ^a,b   Buring, Julie ^a,b   Kraft, Peter ^a   De Vivo, Immaculata ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Endometrial carcinoma; HSD17b2; HSD17b4; Polymorphisms

Indexed keywords

ESTRADIOL; ESTRONE;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; ENDOMETRIUM CANCER; ESTRADIOL BLOOD LEVEL; ESTRONE BLOOD LEVEL; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYDROXYSTEROID DEHYDROGENASE 17B TYPE 2 GENE; HYDROXYSTEROID DEHYDROGENASE 17B TYPE 4 GENE; INTRON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE;

17-HYDROXYSTEROID DEHYDROGENASES; ADULT; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; ESTRADIOL; ESTRADIOL DEHYDROGENASES; ESTRONE; FEMALE; HUMANS; HYDRO-LYASES; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 79952818984     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.11.014     Document Type: Article

References (26)

1. Peltoketo H, Luu-The V, Simard J, Adamski J. 17beta-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family;nomenclature andmain characteristics of the 17HSD/KSR enzymes. J Mol Endocrinol 1999;23:1-11. (Pubitemid 29369554)
2. Husen B, Psonka N, Jacob-Meisel M, Keil C, Rune GM. Differential expression of 17beta-hydroxysteroid dehydrogenases types 2 and 4 in human endometrial epithelial cell lines. J Mol Endocrinol 2000;24:135-44. (Pubitemid 30117667)
3. Yang S, Fang Z, Gurates B, et al. Stromal PRsmediate induction of 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2. Mol Endocrinol 2001;15:2093-105. (Pubitemid 33141129)
4. Luu-The V. Analysis and characteristics of multiple types of human 17beta-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol 2001;76:143-51. (Pubitemid 32510676)
5. Labrie F, Luu-The V, Lin SX, et al. The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology. Steroids 1997;62:148-58. (Pubitemid 27066999)
6. Karageorgi S, Hankinson SE, Kraft P, De Vivo I. Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study cohort 1976-2004. Int J Cancer 2010;126:208-16.
7. Parazzini F, La Vecchia C, Moroni S, Chatenoud L, Ricci E. Family history and the risk of endometrial cancer. Int J Cancer 1994;59:460-2. (Pubitemid 24357267)
8. Olson SH, Bandera EV, Orlow I. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review. Am J Epidemiol 2007;165:235-45. (Pubitemid 46174747)
9. Dunning AM, Dowsett M, Healey CS, et al. Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 2004;96:936-45. (Pubitemid 38868140)
10. Mononen N, Seppala EH, Duggal P, et al. Profiling genetic variation along the androgen biosynthesis and metabolism pathways implicates several single nucleotide polymorphisms and their combinations as prostate cancer risk factors. Cancer Res 2006;66:743-7. (Pubitemid 43165937)
11. Su MT, Chen CH, Kuo PH, et al. Polymorphisms of estrogen-related genes jointly confer susceptibility to human spermatogenic defect. Fertil Steril 2010;93:141-9.
12. Warren R, Skinner J, Sala E, et al. Associations among mammographic density, circulating sex hormones, and polymorphisms in sex hormone metabolism genes in postmenopausal women. Cancer Epidemiol Biomark Prev 2006;15:1502-8. (Pubitemid 44299323)
13. Figueroa JD, Sakoda LC, Graubard BI, et al. Genetic variation in hormone metabolizing genes and risk of testicular germ cell tumors. Cancer Causes Control 2008;19:917-29.
14. Beesley J, Jordan SJ, Spurdle AB, et al. Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set. Cancer Epidemiol Biomark Prev 2007;16:2557-65. (Pubitemid 351196309)
15. Ross RW, Oh WK, Xie W, et al. Inherited variation in the androgen pathway is associated with the efficacy of androgen-deprivation therapy in men with prostate cancer. J Clin Oncol 2008;26:842-7. (Pubitemid 351398074)
16. Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. Jama 2005;294:56-65. (Pubitemid 41002839)
17. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293-304.
18. Cook NR, Lee IM, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. Jama 2005;294:47-55. (Pubitemid 41002838)
19. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 2004;96:1856-65. (Pubitemid 40081323)
20. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001;125:279-84. (Pubitemid 33000466)
21. McGrath M, Lee IM, Buring J, Hunter DJ, De Vivo I. Novel breast cancer risk alleles and endometrial cancer risk. Int J Cancer 2008;123:2961-4.
22. Rantakari P, Strauss L, Kiviranta R, et al. Placenta defects and embryonic lethality resulting from disruption of mouse hydroxysteroid (17-beta) dehydrogenase 2 gene. Mol Endocrinol 2008;22:665-75. (Pubitemid 351397793)
23. Shen Z, Saloniemi T, Ronnblad A, Jarvensivu P, Pakarinen P, Poutanen M. Sex steroid-dependent and -independent action of hydroxysteroid (17beta) Dehydrogenase 2: evidence from transgenic female mice. Endocrinology 2009;150:4941-9.
24. Huyghe S, Mannaerts GP, Baes M, Van Veldhoven PP. Peroxisomal multifunctional protein-2: the enzyme, the patients and the knockout mouse model. Biochim Biophys Acta 2006;1761:973-94.
25. Moller G, van Grunsven EG, Wanders RJ, Adamski J.Molecular basis of D-bifunctional protein deficiency. Mol Cell Endocrinol 2001;171:61-70. (Pubitemid 32098198)
26. Breitling R, Marijanovic Z, Perovic D, Adamski J. Evolution of 17beta-HSD type 4, a multifunctional protein of beta-oxidation. Mol Cell Endocrinol 2001;171:205-10. (Pubitemid 32098216)